Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model.

The difference in the levels of populations of myeloid origin varied greatly between tumors and did not reach statistical significance between the vaccine-treated and mock-treated groups ( Figure 5 D).

also in 111,027 other papers